Physician

Abraham Pachikara, M.D.

According to 2025 Medicare claims, Abraham Pachikara, M.D. (NPI: 1699939256) practices psychiatry in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is PROSPECT HEALTH ACCESS NETWORK, INC. (NPI: 1700231297; TIN: 141338544) and primary practice location at 19013-3902. Pachikara is affiliated with the Crozer ACO (ACO ID: A4711) and Aledade 150 PACHC MSSP Enhanced (ACO ID: A5348), participating under the MSSP model.

Pachikara's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 24 traditional Medicare patients, billed 284 HCPCS/CPT codes, and received $19,251 in Medicare payments. The top billing code was 90836 (Psychotherapy with evaluation and management visit, 45 minutes). Part D data shows 1,426 prescription claims across 55 beneficiaries totaling $59,115 in drug costs, led by Lurasidone Hcl (Lurasidone Hcl). Open Payments data shows 17 records totaling $425. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $5,572 and ending at $19,251. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $243,995 to $59,115. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$14K$28K2015 Medicare payment: $5,572 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $24,517 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $27,899 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $16,558 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $16,351 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $21,538 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $26,583 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $23,834 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $26,134 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $19,251 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153978$5,572
201695382$24,517
2017115498$27,899
201872249$16,558
201924245$16,351
202015313$21,538
202117369$26,583
202222319$23,834
202324358$26,134
202424284$19,251

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$122K$244K2015 Drug cost: $243,995 (USD; Tot_Drug_Cst)2016 Drug cost: $84,264 (USD; Tot_Drug_Cst)2017 Drug cost: $40,144 (USD; Tot_Drug_Cst)2018 Drug cost: $45,426 (USD; Tot_Drug_Cst)2019 Drug cost: $46,776 (USD; Tot_Drug_Cst)2020 Drug cost: $53,160 (USD; Tot_Drug_Cst)2021 Drug cost: $81,336 (USD; Tot_Drug_Cst)2022 Drug cost: $93,306 (USD; Tot_Drug_Cst)2023 Drug cost: $62,093 (USD; Tot_Drug_Cst)2024 Drug cost: $59,115 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151782,229$243,995
20161161,198$84,264
201781825$40,144
201838781$45,426
201938950$46,776
2020491,129$53,160
2021621,391$81,336
2022501,236$93,306
2023701,396$62,093
2024551,426$59,115

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90836Psychotherapy with evaluation and management visit, 45 minutes19114$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more23152$66

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Lurasidone HclLurasidone Hcl19787$10,008
Doxepin HclDoxepin Hcl391,154$4,735
Duloxetine HclDuloxetine Hcl1195,156$2,232
Quetiapine FumarateQuetiapine Fumarate1294,830$2,092
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine571,730$2,089

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$425Neurocrine Biosciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abraham Pachikara, M.D.?

Tedicare shows public-source Medicare data for Abraham Pachikara, M.D. (NPI 1699939256), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abraham Pachikara, M.D. have ACO affiliation data?

Abraham Pachikara, M.D. is shown with ACO affiliation data for Crozer ACO (MSSP, ACO ID A4711) and Aledade 150 PACHC MSSP Enhanced (MSSP, ACO ID A5348).

What billing organization is linked to Abraham Pachikara, M.D.?

Abraham Pachikara, M.D. is linked to PROSPECT HEALTH ACCESS NETWORK, INC. (billing NPI 1700231297) in the available physician profile data.

Does Abraham Pachikara, M.D. have Open Payments data?

Abraham Pachikara, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.